NEW YORK, Sept. 28, 2017 /PRNewswire/ — The Journal of Human Hypertension has just published a study that found adults with high blood pressure were able to lower their risk of hypertension by using Noom’s mobile Hypertension Reduction and Prevention Program (HRPP). This is the first study to prove the short-term efficacy of any HRPP administered through a mobile platform.
The study — “Efficacy of a mobile hypertension prevention delivery platform with human coaching” — demonstrated how a mobile program supported by human coaches was able to help adults with prehypertension and hypertension reduce their blood pressure and lose weight.
Noom’s Hypertension Reduction and Prevention Program includes in-app human coaching along with meal logging, blood pressure tracking, and educational material. Consumers can access Noom’s Hypertension Reduction and Prevention Program on any smartphone.
The goal of the research was to identify how effective HRPP is and how it can help people already suffering from hypertension or prehypertension. Roughly one in three American adults — or 75 million Americans — battle high blood pressure, according to the CDC. The health condition greatly increases the risk for heart attack, heart failure, strokes, and kidney failure.
A Closer Look at the Research Findings and Conclusions
The study, “Efficacy of a mobile hypertension prevention delivery platform with human coaching,” found that 80 percent of the participants who began the study completed the program.
55 percent of participants who completed the program lowered their risk of hypertension, while 40 percent of participants who completed the program lost more than five percent of their body weight. The mean reduction in systolic blood pressure was 7.75 mmHg. Higher frequency of weigh-ins and meal logging, was a consistent and key factor for risk reduction.
“Our research concluded that those who were more engaged in the study had better results and larger reductions in both weight and blood pressure,” said Dr. Toro-Ramos. “The Hypertension Reduction and Prevention Program is different from anything else available to the public because it is individualized in every way. In the study, no single participant had the same medical history nor the exact same experience, yet most shared similar results. The vast majority lost weight and many were normotensive, achieving a blood pressure level within a normal range.”
Before the study, none of the participants were normotensive; 54 percent were prehypertensive, 32 percent had stage 1 hypertension and 14 percent had stage 2 hypertension. The final results showed that after 24 weeks, 30 percent were normotensive, 62.5 percent were prehypertensive, and only 7.5 percent had stage 1 hypertension; none had stage 2 hypertension.
How the Study was Conducted
This pilot study was administered through Noom, a mobile behavior change platform with human coaching. Participants were asked to engage in this mobile intervention between January 2016 and July 2016. All of the study’s participants were prehypertensive or hypertensive.
Each participant received a unique and personalized curriculum that included dietary guidance, suggested physical activities, educational content, interaction with live coaches, and food and activity logging.
Noom’s main outcome variables included change in systolic and diastolic blood pressure, hypertension category, and general weight loss.
The CEO of Noom, Saeju Jeong, says this new research on hypertension will help people with high blood pressure around the world lead healthier lives.
“Noom has helped people achieve meaningful weight loss and lasting behavior change, while bringing insight into what makes people more successful, as well as what factors can encourage or impede success,” said Jeong. “Though our outcomes are second-to-none, we are always striving to learn and improve. More than 45 million people use Noom around the world, so there is never any shortage of data to help us progress.”
About Noom, Inc.
Noom, Inc., a leader in mobile health coaching, combines the power of technology with the empathy of real human coaches to deliver successful behavior change at scale. Noom’s direct-to-consumer weight loss and fitness mobile applications have reached more than 45 million users worldwide. Leveraging the success of their ground-breaking health and fitness programs, Noom developed a behavior change platform to treat chronic and pre-chronic conditions, beginning with the CDC’s Diabetes Prevention Program (DPP). Noom is the first fully mobile diabetes prevention program to be recognized by the CDC and the only mobile program clinically proven in a peer-reviewed journal. Noom offers curricula across the acuity spectrum and now features programs for pre-hypertension, hypertension and diabetes management in addition to its flagship weight loss and diabetes prevention programs. Noom has offices in New York City, Seoul and Tokyo.